-
Neurocrine Biosciences (NASDAQ:NBIX) Rating Lowered to "Buy" at StockNews.com
Source: Buzz FX / 02 Nov 2024 22:26:15 America/Chicago
Neurocrine Biosciences (NASDAQ:NBIX) Rating Lowered to "Buy" at StockNews.com Written by MarketBeat November 2, 2024 Share Link copied to clipboard. Neurocrine Biosciences ( NASDAQ:NBIX - Get Free Report ) was downgraded by equities researc
Read more...